PMTI Palomar Medical Technologies, Inc. (MM)

Palomar Upgrades to Nasdaq National Market BURLINGTON, Mass., March 18 /PRNewswire-FirstCall/ -- Palomar Medical Technologies Inc reports today its common stock has begun trading on the Nasdaq National Market System. Palomar has met all the requirements for listing on the Nasdaq National Market and has upgraded from the Nasdaq Small Cap Market System while retaining the same ticker symbol, PMTI. "We are extremely proud of Palomar's ability to meet the listing criteria for the Nasdaq National Market," stated Chief Executive Officer Joseph P. Caruso. "The listing serves as an endorsement that Palomar has met the stringent requirements outlined by Nasdaq for listing on its national market and reiterates our growing position on Wall Street." Chief Financial Officer Paul S. Weiner commented, "Trading on the Nasdaq National Market could result in increased visibility among institutional investors with listing restrictions and additional analyst coverage." About Palomar Medical Technologies Inc: Palomar is a leading researcher and developer of light-based systems for hair removal and other cosmetic treatments. Last year, Palomar and The Gillette Company (NYSE:G) entered into an agreement to complete development and commercialize a patented home-use, light-based hair removal device for women. New and exciting indications are being tested to further advance the hair removal market and other cosmetic applications. Palomar pioneered the optical hair removal field, when, in 1997, it introduced the first high-powered laser hair removal system. Since then, many of the major advances in light-based hair removal have been based on Palomar technology. There are now millions of light-based cosmetic procedures performed around the world every year inphysician offices, clinics, spas and salons. For more information on Palomar and its products, visit Palomar's website at http://www.palomarmedical.com/. To continue receiving the most up-to-date information and latest news on Palomar as it happens, sign up to receive automatic e-mail alerts by going to the E-mail Alerts page in the Investor Relations' section of the website. With the exception of the historical information contained in this release, the matters described herein contain forward-looking statements, including but not limited to statements relating to new markets, development and introduction of new products, and financial projections that involve risk and uncertainties that may individually or mutually impact the matters herein, and cause actual results, events and performance to differ materially from such forward-looking statements. These risk factors include, but are not limited to, results of future operations, technological difficulties in developing or introducing new products, the results of future research, lack of product demand and market acceptance for current and future products, the effect of economic conditions, challenges in managing joint ventures and research with third parties, the impact of competitive products and pricing, governmental regulations with respect to medical devices, including whether FDA clearance will be obtained for future products, the results of litigation, difficulties in collecting royalties, potential infringement of third-party intellectual property rights, and/or other factors, which are detailed from time to time in the Company's SEC reports, including the report on Form 10-K for the year ended December 31, 2003 and the Company's quarterly reports on Form 10-Q. Readers are cautioned not to place undue reliance on these forward- looking statements, which speak only as of the date hereof. The Company undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. Contacts: Investor Relations Palomar Medical Technologies Inc 781-993-2411 DATASOURCE: Palomar Medical Technologies, Inc. CONTACT: Investor Relations: Palomar Medical Technologies Inc, +1-781-993-2411, Web site: http://www.palmed.com/ Company News On-Call: http://www.prnewswire.com/comp/107555.html

Copyright